GlaxoSmithKline Services Unlimited RE: Comment on Potential Amendment to Federal Rule of Evidence 702

Comments

Oct 12

Written by Matt Brafman

View the document here.

Expert Evidence (including Rule 702)

Jonathan Redgrave, Redgrave LLP: Re: Submission to Advisory Committee on Civil Rules in Support of Examining Rulemaking Regarding Privilege Logs

Tucker Ellis LLP RE: Amending Federal Rule of Evidence 702